Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Consolidated Net Profit

    Back to Income Statement
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹27 Cr₹15 Cr₹10 Cr₹7.37 Cr₹3.67 Cr

What is the latest Consolidated Net Profit of KILITCH DRUGS (INDIA) ?

The latest Consolidated Net Profit ratio of KILITCH DRUGS (INDIA) is ₹27 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹27 Cr
Mar2024₹15 Cr
Mar2023₹10 Cr
Mar2022₹7.37 Cr
Mar2021₹3.67 Cr

How is Consolidated Net Profit of KILITCH DRUGS (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹27 Cr
82.87
Mar2024 ₹15 Cr
39.75
Mar2023 ₹10 Cr
41.82
Mar2022 ₹7.37 Cr
100.68
Mar2021 ₹3.67 Cr -

Compare Consolidated Net Profit of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹644.0 Cr 2.3% 1.6% -11.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,815.0 Cr 0.5% 6.2% 17.3% Stock Analytics
DIVIS LABORATORIES ₹192,678.0 Cr 4.7% 9% 7% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,323.0 Cr -3.7% 7.2% 49.8% Stock Analytics
CIPLA ₹114,585.0 Cr -0.6% 5% -3.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,067.0 Cr -1.9% -4.6% -2.8% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

2.3%

1.6%

-11.8%

SENSEX

0.8%

1.8%

-6.5%


You may also like the below Video Courses